Earnings Surprise: Social media buzz around UnitedHealth Group's recent quarterly results highlighted a significant beat on both revenue and adjusted earnings. Investors noted the improved medical benefit ratio, signaling better cost controls after periods of elevated utilization. The company also raised its full-year guidance, sparking discussions on potential stabilization in the healthcare sector.
Portfolio Adjustments: Traders shared updates on rebalancing their holdings, with some reducing positions in UnitedHealth to allocate toward other opportunities while maintaining long-term confidence. Discussions emphasized the company's scale in insurance and Optum services as key strengths. Overall, participants viewed the moves as tactical rather than a shift in fundamental outlook.
Future Outlook: Conversations turned to ongoing challenges like GLP-1 drug costs and regulatory pressures, yet many expressed optimism about AI-driven efficiencies aiding recovery. The stock's response to the earnings release fueled debates on whether margins can sustain improvement amid industry headwinds. Social media sentiment reflects a blend of relief and vigilance toward upcoming policy developments.
Note: This discussion summary was generated from an AI condensation of post data.
UnitedHealth Group Revenue
UnitedHealth Group had revenues of $111.7B in Q1 2026. This is an increase of 1.96% from the same period in the prior year.
You can track UNH financials on Quiver Quantitative's UNH stock page.
You can access data on UNH stock through the Quiver Quantitative API.
UnitedHealth Group Congressional Stock Trading
Members of Congress have traded $UNH stock 11 times in the past 6 months. Of those trades, 8 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/22 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 3 purchases worth up to $80,000 on 04/14, 03/13, 12/19 and 1 sale worth up to $50,000 on 02/10.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 03/19.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
- REPRESENTATIVE KEVIN HERN sold up to $500,000 on 12/23.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 12/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
UnitedHealth Group Hedge Fund Activity
We have seen 1,336 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 1,956 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 12,377,403 shares (+146.6%) to their portfolio in Q1 2026, for an estimated $3,327,664,796
- CAPITAL RESEARCH GLOBAL INVESTORS added 10,850,420 shares (+173.3%) to their portfolio in Q1 2026, for an estimated $2,917,135,417
- CAPITAL INTERNATIONAL INVESTORS removed 9,653,799 shares (-51.7%) from their portfolio in Q1 2026, for an estimated $2,595,423,861
- WELLINGTON MANAGEMENT GROUP LLP removed 5,597,135 shares (-35.7%) from their portfolio in Q1 2026, for an estimated $1,504,789,744
- CAPITAL WORLD INVESTORS added 5,192,373 shares (+23.0%) to their portfolio in Q1 2026, for an estimated $1,395,969,481
- BERKSHIRE HATHAWAY INC removed 5,039,564 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,354,886,781
- ROYAL BANK OF CANADA removed 2,749,844 shares (-34.1%) from their portfolio in Q1 2026, for an estimated $739,295,559
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
UnitedHealth Group Government Contracts
We have seen $16,234,388,316 of award payments to $UNH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
- EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
- EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
- EXPRESS REPORT: R3 FY25 2ND QTR FEBRUARY: $730,504,137
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
UnitedHealth Group Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/05/2026
- Truist Securities issued a "Buy" rating on 02/02/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Wells Fargo issued a "Overweight" rating on 01/30/2026
- Jefferies issued a "Buy" rating on 01/28/2026
- Leerink Partners issued a "Outperform" rating on 01/28/2026
To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.
UnitedHealth Group Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 18 analysts offer price targets for $UNH in the last 6 months, with a median target of $396.0.
Here are some recent targets:
- Lisa Gill from JP Morgan set a target price of $420.0 on 04/28/2026
- Ryan Langston from TD Cowen set a target price of $337.0 on 04/23/2026
- Michael Wiederhorn from Oppenheimer set a target price of $405.0 on 04/22/2026
- Whit Mayo from Leerink Partners set a target price of $400.0 on 04/22/2026
- Ben Hendrix from RBC Capital set a target price of $400.0 on 04/22/2026
- Stephen Baxter from Wells Fargo set a target price of $397.0 on 04/22/2026
- David Toung from Argus Research set a target price of $400.0 on 04/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
